Status:
ACTIVE_NOT_RECRUITING
Oncological Safety of Oncoplastic Breast Surgery in Multicentric Breast Cancer
Lead Sponsor:
Assiut University
Conditions:
Safety of Breast Coservative Multicenteric Breast Cancer
Breast Neoplasms
Eligibility:
FEMALE
18-65 years
Brief Summary
The purpose of the study is to evaluate Oncological safety of oncoplastic breast surgery in multicentric breast cancer
Detailed Description
Breast cancer is the most prevalent cancer in women worldwide, accounting for about 23.8%. Multifocal and multicentric breast tumors are defined as two or more neoplasms separated in one breast. In mu...
Eligibility Criteria
Inclusion
- Female patients with multicentric breast cancer
- Female Patient aged from 18 to 65 years old
- Patients who are fit for general anesthesia.
- Patients who provide a written informed consent.
- Patient who agree to provide short term outcome data and agree to provide contact information to provide contact information
Exclusion
- Female patients less than 20 years old
- Stage 4 breast cancer
- Patients who are contraindicated for radiotherapy
- Pregnant patients in first trimester
- Patient with inflammatory carcinoma
Key Trial Info
Start Date :
March 19 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 19 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06926335
Start Date
March 19 2025
End Date
April 19 2026
Last Update
April 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuit University
Asyut, Egypt